<i>TRPC6</i> Gene Variants in Czech Adult Patients with Focal Segmental Glomerulosclerosis and Minimal Change Disease Cited by

Fol. Biol. 2012, 58, 173-176

https://doi.org/10.14712/fb2012058040173

TRPC6 Gene Variants in Czech Adult Patients with Focal Segmental Glomerulosclerosis and Minimal Change Disease

L. Obeidová¹, Jana Reiterová^1,2, P. Lněnička¹, J. Štekrová¹, H. Šafránková², M. Kohoutová¹, V. Tesař²

¹Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
²Department of Nephrology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic

Received November 2011
Accepted February 2012

Crossref Cited-by Linking

Staruschenko Alexander, Ma Rong, Palygin Oleg, Dryer Stuart E.: Ion channels and channelopathies in glomeruli. Physiological Reviews 2023, 103, 787. <https://doi.org/10.1152/physrev.00013.2022>
Tu Yu-Chi, Shu Hua-Pan, Sun Lu-Lu, Liao Qian-Qian, Feng Li, Ren Ming, Yao Li-Jun: The Physiopathologic Roles of Calcium Signaling in Podocytes. Front. Biosci. (Landmark Ed) 2023, 28. <https://doi.org/10.31083/j.fbl2810240>
Dryer Stuart E., Kim Eun Young: The Effects of TRPC6 Knockout in Animal Models of Kidney Disease. Biomolecules 2022, 12, 1710. <https://doi.org/10.3390/biom12111710>
Liu Zhiying, Zhang Haiyan, Zhao Shipeng, Zhang Qian, Zhang Ruixiao, Han Yue, Shao Leping, Zhao Xiangzhong: Novel gain\u2010of\u2010function mutation of TRPC6 Q134P contributes to late onset focal segmental glomerulosclerosis in a Chinese pedigree. Nephrology 2021, 26, 1018. <https://doi.org/10.1111/nep.13963>
Hubá\u010dek Jaroslav A., Pikhart H., Peasey A., Kubínová R., Bobák M.: Nobody Is Perfect: Comparison of the Accuracy of PCR-RFLP and KASP\u2122 Method for Genotyping. ADH1B and FTO Polymorphisms as Examples. Fol. Biol. 2015, 61, 156. <https://doi.org/10.14712/fb2015061040156>
Bloudí\u010dková Silvie, Kuthanová L., Hubá\u010dek J. A.: MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development. Fol. Biol. 2014, 60, 83. <https://doi.org/10.14712/fb2014060020083>